Highlights ■ The treatment of Hepatorenal Syndrome places a huge economic burden on healthcare systems. ■ Cost analysis studies of Hepatorenal Syndrome management can help to rationally allocate resources in healthcare. ■ Timely diagnosis and management of Hepatorenal Syndrome may reduce mortality, resource utilization and costs. ABSTRACT Objective: The purpose of this study was to describe the direct medical costs incurred in Brazil for the treatment of Hepatorenal Syndrome in intensive care and intermediate therapy care units, and to investigate […]

ABSTRACT Objective: To estimate the direct medical costs of drug therapy of Klebsiella pneumoniae carbapenemase (KPC) infection patients in hospital-based context. Methods: A cost-of-illness study conducted with a prospective cohort design with hospitalized adults infected by KPC. Data collection was performed using an instrument composed of sociodemographic data, clinical and prescription medication. Estimates of the direct costs associated to each treatment were derived from the payer’s perspective, in the case of federal public hospitals from Brazil, and included only drug […]